P

Pacific Biosciences

Long-Read Sequencing Technology

Menlo Park, CA
1,200+

About Pacific Biosciences

Industry: Genomics
Founded: 2004
Founders: Stephen Turner, Jonas Korlach
Status: Public (NASDAQ: PACB)

Funding & Growth

Total Raised: $800M+
Valuation: $3B+ market cap
Stage: Public
Key Investors:
Public markets

✓ Pros

  • • Leading long-read technology
  • • Innovative science
  • • Bay Area location
  • • Strong R&D culture
  • • Growing market share

✗ Cons

  • • Stock volatility
  • • Competition with ONT
  • • Smaller company resources
  • • Cost of instruments

Get weekly job alerts